Children with ANCA-associated vasculitis (AAV) often have more active inflammation of the kidneys, as well as more severe signs of kidney disease, than do adults with AAV, according to a new study from France and Italy. Still, with monitoring and treatment, the long-term outcomes for pediatric patients are similar…
Discussion
Many of us living with ANCA-associated vasculitis become familiar at some point with the “spoon theory.” It’s a simple yet powerful way to understand energy as a limited resource — something we have to consciously budget throughout the day. For many of us, discovering this framework shortly after a…
Following allegations of manipulated data in its regulatory application, a division of the U.S. Food and Drug Administration (FDA) has proposed withdrawing Tavneos (avacopan), an oral treatment approved for the most common forms of ANCA-associated vasculitis (AAV), from the market. In a press announcement, the FDA’s Center…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
